Japan to India: Diagnostic Import Trade Route

The Japan to India Diagnostic corridor is one of India's established pharmaceutical import routes from Japan, with 328 shipments documented worth a combined $55.6M USD. The route is dominated by DENKA COMPANY LIMITED , which alone accounts for roughly 86% of all import value, reflecting the consolidated nature of Japan's diagnostic export sector.

Across 7 active Japan suppliers, the average shipment value stands at $169.4K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 76% of all shipments, consistent with diagnostic's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 15 days port-to-port. The route has recorded an annual growth rate of 32.1%, placing it at rank #16 among India's top diagnostic import origins globally.

On the Indian buyer side, key Indian importers include AGAPPE DIAGNOSTICS LIMITED , AGAPPE DIAGNOSTICS LIMITED, ARKRAY HEALTHCARE PRIVATE LIMITED . AGAPPE DIAGNOSTICS LIMITED is the single largest Indian importer with 160 shipments valued at $54.4M USD.

India's diagnostic imports from Japan are driven primarily by a handful of large-scale Japan manufacturers. DENKA COMPANY LIMITED with 16 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 7 active exporters signals a competitive but concentrated market — Indian buyers benefit from Japan supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — DENKA COMPANY LIMITED , FUJIREBIO INC , DENKA COMPANY LIMITED — together account for 98% of total trade value on this route. The average shipment value of $169.4K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as rf(ii) latex (r2) - (diagnostic reagent) and alp conjugated anti-prg antibody #c1goapb00 (raw material for diagnostic reagent for research study) , suggesting that Indian buyers tend to consolidate orders across related product lines from the same Japan supplier.

On the buying side, AGAPPE DIAGNOSTICS LIMITED is the largest importer with 160 shipments worth $54.4M USD — representing 98% of all diagnostic imports from Japan on this route.